Modulating the genomic programming of adipocytes

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 80, Issue , 2016, Pages 239-248

  Loft, Anne ^a   Schmidt, Søren Fisker ^a   Mandrup, Susanne ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 11; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CELL CYCLE PROTEIN; KLF11 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ADIPOCYTE; ADIPOGENESIS; BROWN ADIPOCYTE; CELL FUNCTION; CONFERENCE PAPER; GENE EXPRESSION; GENOMICS; HUMAN; INFLAMMATION; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN BINDING; WHITE ADIPOCYTE; AGONISTS; ANIMAL; CELL PLASTICITY; CELL REPROGRAMMING TECHNIQUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ARTICLE; ENHANCER REGION; GENE REPRESSION; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOCYTES, BROWN; ADIPOCYTES, WHITE; ANIMALS; CELL CYCLE PROTEINS; CELL PLASTICITY; CELLULAR REPROGRAMMING; CELLULAR REPROGRAMMING TECHNIQUES; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; NF-KAPPA B; PPAR GAMMA; REPRESSOR PROTEINS; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84978698301     PISSN: 00917451     EISSN: 19434456     Source Type: Book Series    
DOI: 10.1101/sqb.2015.80.027516     Document Type: Conference Paper

References (84)

1. Arner E, Mejhert N, Kulyté A, Balwierz PJ, Pachkov M, Cormont M, Lorente-Cebrián S, Ehrlund A, Laurencikiene J, Hedén P, et al. 2012. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61: 1986-1993.
2. Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, Elbrecht A, Johnson BA, Zhou G, Doebber TW, et al. 2003. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [g] selective modulator. Mol Endocrinol 17: 662-676.
3. Boergesen M, Pedersen TA, Gross B, van Heeringen SJ, Hagenbeek D, Bindesbøll C, Caron S, Lalloyer F, Steffensen KR, Nebb HI, et al. 2012. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor a in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 32: 852-867.
4. Bogacka I, Xie H, Bray GA, Smith SR. 2005. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54: 1392-1399.
5. Brown JD, Lin CY, Duan Q, Griffin G, Federation AJ, Paranal RM, Bair S, Newton G, Lichtman AH, Kung AL, et al. 2014. NF-kB directs dynamic super-enhancer formation in inflammation and atherogenesis. Mol Cell 56: 219-231.
6. Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, Reitman ML. 2000. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106: 1221-1228.
7. Choi JH, Banks AS, Estall JL, Kajimura S, BoströmP, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARg by Cdk5. Nature 466: 451-456.
8. Crawford GE, Holt IE, Whittle J, Webb BD, Tai D, Davis S, Margulies EH, Chen Y, Bernat JA, Ginsburg D, et al. 2006. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 16: 123-131.
9. Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins JB. 1998. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 47: 138-141.
10. Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ, Kliewer SA. 2012. Fibroblast growth factor-21 regulates PPARg activity and the antidiabetic actions of thiazolidinediones. Cell 148: 556-567.
11. Elabd C, Chiellini C, Carmona M, Galitzky J, Cochet O, Petersen R, Pénicaud L, Kristiansen K, Bouloumié A, Casteilla L, et al. 2009. Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes. Stem Cells 27: 2753-2760.
12. Fukui Y, Masui S, Osada S, Umesono K, Motojima K. 2000. A new thiazolidinedione, NC-2100, which is a weak PPAR-g activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes 49: 759-767.
13. Gao Z, He Q, Peng B, Chiao PJ, Ye J. 2006. Regulation of nuclear translocation of HDAC3 by IkBa is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor g function. J Biol Chem 281: 4540-4547.
14. Gerhold DL, Liu F, Jiang G, Li Z, Xu J, Lu M, Sachs JR, Bagchi A, Fridman A, Holder DJ, et al. 2002. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-g agonists. Endocrinology 143: 2106-2118.
15. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan K-K, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489: 91-100.
16. Guertin MJ, Zhang X, Coonrod SA, Hager GL. 2014. Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes. Mol Endocrinol 28: 1522-1533.
17. Guilherme A, Virbasius JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
18. Haakonsson AK, Stahl Madsen M, Nielsen R, Sandelin A, Mandrup S. 2013. Acute genome-wide effects of rosiglitazone on PPARg transcriptional networks in adipocytes. Mol Endocrinol 27: 1536-1549.
19. Hamza MS, Pott S, Vega VB, Thomsen JS, Kandhadayar GS, Ng PW, Chiu KP, Pettersson S, Wei CL, Ruan Y, et al. 2009. Denovo identification of PPARg/RXR binding sites and direct targets during adipogenesis. PLoS One 4: e4907.
20. He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM. 2003. Adipose-specific peroxisome proliferator-activated receptor g knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci 100: 15712-15717.
21. He HH, Meyer CA, Chen MW, Jordan VC, Brown M, Liu XS. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res 22: 1015-1025.
22. Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, Bradner JE, Young RA. 2015. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell 58: 362-370.
23. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM. 1994. Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134: 264-270.
24. Hurst LD, Sachenkova O, Daub C, Forrest AR, Huminiecki L, FANTOM consortium. 2014. A simple metric of promoter architecture robustly predicts expression breadth of human genes suggesting that most transcription factors are positive regulators. Genome Biol 15: 413.
25. Ing-Simmons E, Seitan VC, Faure AJ, Flicek P, Carroll T, Dekker J, Fisher AG, Lenhard B, Merkenschlager M. 2015. Spatial enhancer clustering and regulation of enhancer-proximal genes by cohesin. Genome Res 25: 504-513.
26. Ishibashi J, Seale P. 2010. Medicine. Beige can be slimming. Science 328: 1113-1114.
27. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, et al. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
28. Kang S, Tsai LT, Zhou Y, Evertts A, Xu S, Griffin MJ, Issner R, Whitton HJ, Garcia BA, Epstein CB, et al. 2015. Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis. Nat Cell Biol 17: 44-56.
29. Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL. 2007. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol 27: 5090-5104.
30. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA. 2005. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: Increased expression of inflammation- related genes. Diabetologia 48: 1776-1783.
31. Lee JE, Wang C, Xu S, Cho Y-W, Wang L, Feng X, Baldridge A, Sartorelli V, Zhuang L, PengW, et al. 2013. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. Elife 2: e01503.
32. Lee M-W, Odegaard JI, Mukundan L, Qiu Y, Molofsky AB, Nussbaum JC, Yun K, Locksley RM, Chawla A. 2015. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160: 74-87.
33. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, Feng D, Zhuo D, Stoeckert CJ Jr, Liu XS, et al. 2008. PPARg and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22: 2941-2952.
34. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor g (PPARγ). J Biol Chem 270: 12953-12956.
35. Lo KA, Labadorf A, Kennedy NJ, Han MS, Yap YS, Matthews B, Xin X, Sun L, Davis RJ, Lodish HF, et al. 2013. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Rep 5: 259-270.
36. Loft A, Forss I, Siersbæk MS, Schmidt SF, Larsen A-S, Madsen JGS, Pisani DF, Nielsen R, Aagaard MM, Mathison A, et al. Browning of human adipocytes requires KLF11 and reprogramming of PPARg super-enhancers. Genes Dev 29: 7-22.
37. Lovén J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320-334.
38. Madsen MS, Siersbaek R, Boergesen M, Nielsen R, Mandrup S. Peroxisome proliferator-activated receptor g and C/ EBPa synergistically activate key metabolic adipocyte genes by assisted loading. Mol Cell Biol 34: 939-954.
39. Madsen JGS, Schmidt SF, Larsen BD, Loft A, Nielsen R, Mandrup S. 2015. iRNA-seq: Computational method for genomewide assessment of acute transcriptional regulation from total RNA-seq data. Nucleic Acids Res 43: e40.
40. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, et al. 2001. PPARg ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099.
41. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57: 433-442.
42. Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, Rosen ED. 2010. Comparative epigenomic analysis of murine and human adipogenesis. Cell 143: 156-169.
43. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Børgesen M, Francoijs K-J, Mandrup S, et al. 2008. Genome-wide profiling of PPARg:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 22: 2953-2967.
44. Oger F, Dubois-Chevalier J, Gheeraert C, Avner S, Durand E, Froguel P, Salbert G, Staels B, Lefebvre P, Eeckhoute J. 2014. Peroxisome proliferator-activated receptor g regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes. J Biol Chem 289: 708-722.
45. Ohno H, Shinoda K, Spiegelman BM, Kajimura S. 2012. PPARg agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15: 395-404.
46. Parker SCJ, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van Bueren KL, Chines PS, Narisu N, NISC Comparative Sequencing Program, et al. 2013. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci 110: 17921-17926.
47. Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J. 2010. Chronic peroxisome proliferator-activated receptor g (PPARg) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285: 7153-7164.
48. Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, Allen J, Swarbrick M, Rose-John S, Rincon M, Robertson G, et al. 2014. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab 20: 433-447.
49. Qi L, Saberi M, Zmuda E, Wang Y, Altarejos J, Zhang X, Dentin R, Hedrick S, Bandyopadhyay G, Hai T, et al. 2009. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab 9: 277-286.
50. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM, Palmiter RD, Chawla A. 2014. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157: 1292-1308.
51. Rajakumari S, Wu J, Ishibashi J, Lim HW, Giang AH, Won KJ, Reed RR, Seale P. 2013. EBF2 determines and maintains brown adipocyte identity. Cell Metab 17: 562-574.
52. Ribon V, Johnson JH, Camp HS, Saltiel AR. 1998. Thiazolidinediones and insulin resistance: Peroxisome proliferator activated receptor g activation stimulates expression of the CAP gene. Proc Natl Acad Sci 95: 14751-14756.
53. Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, et al. 2015. Integrative analysis of 111 reference human epigenomes. Nature 518: 317-330.
54. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. 2002. Tumor necrosis factor-a suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-kB activation by TNF-a is obligatory. Diabetes 51: 1319-1336.
55. Schmidt SF, Jørgensen M, Chen Y, Nielsen R, Sandelin A, Mandrup S. 2011. Cross species comparison of C/EBPa and PPARg profiles in mouse and human adipocytes reveals interdependent retention of binding sites. BMC Genomics 12: 152.
56. Schmidt SF, Larsen BD, Loft A, Nielsen R, Madsen JG, Mandrup S. 2015. Acute TNF-induced repression of cell identity genes is mediated by NFkB-directed redistribution of cofactors from super-enhancers. Genome Res 25: 1281-1294.
57. Sears IB, MacGinnitie MA, Kovacs LG, Graves RA. 1996. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: Regulation by peroxisome proliferator- activated receptor g. Mol Cell Biol 16: 3410-3419.
58. Sears DD, Hsiao A, Ofrecio JM, Chapman J, HeW, Olefsky JM. Selective modulation of promoter recruitment and transcriptional activity of PPARg. Biochem Biophys Res Commun 364: 515-521.
59. Siersbæk R, Mandrup S. 2011. Transcriptional networks controlling adipocyte differentiation. Cold Spring Harb Symp Quant Biol 76: 247-255.
60. Siersbæk R, Nielsen R, John S, Sung M-H, Baek S, Loft A, Hager GL, Mandrup S. 2011. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 30: 1459-1472.
61. Siersbæk MS, Loft A, Aagaard MM, Nielsen R, Schmidt SF, Petrovic N, Nedergaard J, Mandrup S. 2012a. Genome-wide profiling of peroxisome proliferator-activated receptor g in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Mol Cell Biol 32: 3452-3463.
62. Siersbæk R, Nielsen R, Mandrup S. 2012b. Transcriptional networks and chromatin remodeling controlling adipogenesis. Trends Endocrinol Metab 23: 56-64.
63. Siersbaek R, Baek S, Rabiee A, Nielsen R, Traynor S, Clark N, Sandelin A, Jensen ON, Sung MH, Hager GL, et al. 2014a. Molecular architecture of transcription factor hotspots in early adipogenesis. Cell Rep 7: 1434-1442.
64. Siersbæk R, Rabiee A, Nielsen R, Sidoli S, Traynor S, Loft A, Poulsen LLC, Rogowska-Wrzesinska A, Jensen ON, Mandrup S. 2014b. Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep 7: 1443-1455.
65. Smith U, Gogg S, Johansson A, Olausson T, Rotter V, Svalstedt B. 2001. Thiazolidinediones (PPARg agonists) but not PPARa agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes. FASEB J 15: 215-220.
66. Soccio RE, Chen ER, Rajapurkar SR, Safabakhsh P, Marinis JM, Dispirito JR, Emmett MJ, Briggs ER, Fang B, Everett LJ, et al. 2015. Genetic variation determines PPARg function and anti-diabetic drug response in vivo. Cell 162: 33-44.
67. Steger DJ, Grant GR, Schupp M, Tomaru T, Lefterova M, Schug J, Manduchi E, Stoeckert Jr CJ, Lazar MA. 2010. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev 24: 1035-1044.
68. Step SE, Lim HW, Marinis JM, Prokesch A, Steger DJ, You SH, Won KJ, Lazar MA. 2014. Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARg-driven enhancers. Genes Dev 28: 1018-1028.
69. Tam CS, Heilbronn LK, Henegar C, Wong M, Cowell CT, Cowley MJ, Kaplan W, Clément K, Baur LA. 2011. An early inflammatory gene profile in visceral adipose tissue in children. Int J Pediatr Obes 6: e360-e363.
70. Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, Virbasius JV, Nicoloro SM, Straubhaar J, Czech MP. 2006. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARg, adipogenesis, and insulinresponsive hexose transport. Proc Natl Acad Sci 103: 2087-2092.
71. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. 2012. The accessible chromatin landscape of the human genome. Nature 489: 75-82.
72. Tontonoz P, Spiegelman BM. 2008. Fat and beyond: The diverse biology of PPARg. Annu Rev Biochem 77: 289-312.
73. Vernochet C, Peres SB, Davis KE, McDonald ME, Qiang L, Wang H, Scherer PE, Farmer SR. 2009. C/EBPa and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferatoractivated receptor g agonists. Mol Cell Biol 29: 4714-4728.
74. Vierstra J, Rynes E, Sandstrom R, Zhang M, Canfield T, Hansen RS, Stehling-Sun S, Sabo PJ, Byron R, Humbert R, et al. 2014. Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution. Science 346: 1007-1012.
75. Wakabayashi K-I, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I, Kitakami J-I, Ihara S, Hashimoto Y, Hamakubo T, et al. 2009. The peroxisome proliferator-activated receptor g/retinoid X receptor a heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 29: 3544-3555.
76. Waki H, Nakamura M, Yamauchi T, Wakabayashi K, Yu J, Hirose-Yotsuya L, Take K, Sun W, Iwabu M, Okada-Iwabu M, et al. 2011. Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet 7: e1002311.
77. Wang P, Renes J, Bouwman F, Bunschoten A, Mariman E, Keijer J. 2007a. Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: Increase of lipid catabolism and reduction of adipokine expression. Diabetologia 50: 654-665.
78. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M. 2007b. A hierarchical network of transcription factors governs androgen receptordependent prostate cancer growth. Mol Cell 27: 380-392.
79. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AWJr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
80. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, Scherer PE. 2014. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 20: 103-118.
81. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153: 307-319.
82. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, et al. 2012. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150: 366-376.
83. Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, Sandstrom R, Ma Z, Davis C, Pope BD, et al. 2014. A comparative encyclopedia of DNA elements in the mouse genome. Nature 515: 355-364.
84. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE. 1996. Negative regulation of peroxisome proliferator-activated receptor-g gene expression contributes to the antiadipogenic effects of tumor necrosis factor-a. Mol Endocrinol 10: 1457-1466.